NAMA
RPTX

Nikko Asset Management Americas’s Repare Therapeutics RPTX Stock Holding History

Nikko Asset Management Americas’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-116,249
Closed -$162K – 199
2025
Q2 		$162K Hold
116,249
– – ﹤0.01% 189
2025
Q1 		$115K Hold
116,249
– – ﹤0.01% 188
2024
Q4 		$152K Sell
116,249
-132,966
-53% -$396K ﹤0.01% 184
2024
Q3 		$855K Sell
249,215
-27,953
-10% -$92K 0.01% 160
2024
Q2 		$915K Sell
277,168
-31,281
-10% -$112K 0.01% 159
2024
Q1 		$1.43M Sell
308,449
-17,562
-5% -$113K 0.01% 150
2023
Q4 		$2.38M Hold
326,011
– – 0.02% 137
2023
Q3 		$3.94M Buy
326,011
+3,395
+1% +$35K 0.05% 119
2023
Q2 		$3.4M Buy
322,616
+161,018
+100% +$1.66M 0.04% 124
2023
Q1 		$1.47M Sell
161,598
-12,435
-7% -$143K 0.02% 160
2022
Q4 		$2.55M Sell
174,033
-13,004
-7% -$195K 0.04% 143
2022
Q3 		$2.15M Buy
+187,037
New +$2.41M 0.03% 149

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

Nikko Asset Management Americas's RPTX Position: Q3 2025 in Review

Nikko Asset Management Americas sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 116,249 shares — an estimated $162K sold.

Nikko Asset Management Americas first reported a position in RPTX in Q3 2022 and held it in 12 quarters. The position peaked at $3.94M in Q3 2023. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

  • Nikko Asset Management Americas reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nikko Asset Management Americas sold 116,249 Repare Therapeutics shares in Q3 2025, an estimated $162K.
  • Nikko Asset Management Americas first reported a position in Repare Therapeutics in Q3 2022 and held it in 12 quarters.
  • Nikko Asset Management Americas's Repare Therapeutics position peaked at $3.94M in Q3 2023.
  • 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on Nikko Asset Management Americas's 13F filing for Q3 2025, filed 12 Nov 2025.